Return to Statistics Toolbox

OPLS-DA analysis for Study ST002121

(Analysis AN003472 )

Select one or more experimental factors for Groups 1 and 2. The members of each group should be DIFFERENT.
Group1Experimental factorGroup2
Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml normal saline
Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml

  logo